Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Board Member, CEO at Applied Proteomics

Premium

Applied Proteomics announced this week that it has appointed Peter Klemm as CEO and James Blair to its board of directors.

Klemm is currently chairman of Pathwork Diagnostics and was previously the CEO and president of Predictive Biosciences. He was also CEO of GeneOhm Sciences, which was acquired by Becton Dickinson.

Blair is a founding partner at Domain Associates, which recently participated in API's $22.5 million Series B funding round (See story, this issue).

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.